Skip to main content

Advertisement

SpringerLink
Log in

Laboratory aids in the diagnosis of invasive candidiasis

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

The laboratory diagnosis of candidiasis continues to be problematic; however, there have been several advances in the past decade which promise to enhance our ability to identify patients at high risk for infection and/or to document invasive candidiasis in critically ill and immunocompromised patients. The introduction of commercially available biphasic blood culture medium and subsequently the lysiscentrifugation procedure has markedly improved the ability of laboratories to detect fungemia. Although serologic methods have not been very successful in diagnosing candidiasis in immunocompromised patients, several antigen detection methods are now under investigation. In addition, detection of fungal metabolites such as D-arabinitol remains promising. Finally, application of the techniques of molecular biology for typing and detection of fungal pathogens has expanded our understanding of candidal infections and may offer the most sensitive and specific means of diagnosing invasive candidiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bross J, Talbot GH, Maislin G, Hurwitz S. Risk factors for nosocomial candidemia: A case-control study in adults without leukemia. Am J Med 1989; 87: 614–9.

    Google Scholar 

  2. Harvey RL, Myers JP. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 1987; 147: 2117–20.

    Google Scholar 

  3. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 1988; 26: 429–32.

    Google Scholar 

  4. Komshian SV, Uwaydak AK, Sobel JD, Crane LR. Fungemia caused byCandida species andTorulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11: 379–90.

    Google Scholar 

  5. Pfaller MA. NosocomialCandida infections. In: Doebbeling BN, Herwaldt LA, Nettleman MD, Pfaller MA, Wenzel RP, eds. Hospital-acquired infections: New challenges. Kalamazoo, MI: The Upjohn Company, 1991: 61–80.

    Google Scholar 

  6. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital acquired candidemia: A matched case-control study. Arch Intern Med 1989; 149: 2349–53.

    Google Scholar 

  7. Anaisse E, Bodey GP, Kantarjian H, et al. New spectrum of fungal infections in patients with cancer. Rev Infect Dis 1989; 11: 369–78.

    Google Scholar 

  8. Anaisse EJ, Bodey GP, Rinaldi MD. Emerging fungal pathogens. Eur J Clin Microbiol Infect Dis 1989; 8: 323–30.

    Google Scholar 

  9. Anaisse E, Bodey GP. Disseminated trichosporonosis: Meeting the Challenge. Eur J Clin Microbiol Infect Dis 1991; 10: 711–3.

    Google Scholar 

  10. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. Am J Med 1991; 91 (Suppl 3B): 36S-89S.

    Google Scholar 

  11. Wenzel RP, Pfaller MA.Candida species: emerging hospital bloodstream pathogens. Infect Control Hosp Epidemiol 1991; 12: 523–4.

    Google Scholar 

  12. Miller PJ, Wenzel RP. Etiologic organisms as independent predictors of death and morbidity associated with blood-stream infections. J Infect Dis 1987; 156: 471–7.

    Google Scholar 

  13. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital acquired candidemia: The attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642–5.

    Google Scholar 

  14. Hopwood V, Warnock DW. New developments in the diagnosis of opportunistic fungal infection. Eur J Clin Microbiol 1986; 5; 379–88.

    Google Scholar 

  15. Jones JM. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 1990; 3: 32–45.

    Google Scholar 

  16. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal disease during remission-induction therapy for acute myelogenous leukemia. Cancer 1984; 53: 411–9.

    Google Scholar 

  17. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980; 142: 503–9.

    Google Scholar 

  18. Pfaller M, Cabezudo I, Koontz F, Bale M, Gingrich R. Predictive value of surveillance cultures for systemic infection due toCandida species. Eur J Clin Microbiol 1987; 6: 628–33.

    Google Scholar 

  19. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and result of therapy. Rev Infect Dis 1985; 7: 646–55.

    Google Scholar 

  20. Merz WG, Karp JE, Schron D, Saral R. Increased incidence of fungemia caused byCandida krusei. J Clin Microbiol 1986; 24: 581–4.

    Google Scholar 

  21. Wingard JR, Merz WG, Saral R.Candida tropicalis: A major pathogen in immunocompromised patients. Ann Intern Med 1979; 91: 539–43.

    Google Scholar 

  22. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase inCandida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–7.

    Google Scholar 

  23. McCray E, Rampell N, Solomon SL, Bond WW, Martone WJ, O'Day D. Outbreak ofCandida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J Clin Microbiol 1986; 24: 625–8.

    Google Scholar 

  24. Weems JJ Jr, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL.Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987; 25: 1029–32.

    Google Scholar 

  25. Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused byCandida lusitaniae. Rev Infect Dis 1987; 9: 1006–12.

    Google Scholar 

  26. Ness MJ, Vaughan WP, Woods GL.Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients. J Infect Dis 1989; 159: 495–502.

    Google Scholar 

  27. Walsh TJ, Hathorn JW, Sobel JD, et al. Detection of circulatingCandida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 1991; 324: 1026–31.

    Google Scholar 

  28. Dorn GL, Land GA, Wilson GE. Improved blood culture technique based on centrifugation: Clinical evaluation. J Clin Microbiol 1979; 9: 391–6.

    Google Scholar 

  29. Kiehn TE, Wong B, Edwards FF, Armstrong D. Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol 1983; 18: 300–4.

    Google Scholar 

  30. Body BA, Pfaller MA, Durrer J, Koontz F, Groschel DHM. Comparison of the lysis-centrifugation and radiometric blood culture systems for recovery of yeast. Eur J Clin Microbiol Infect Dis 1988; 7: 417–28.

    Google Scholar 

  31. Brannon P, Kiehn TE. Large scale clinical comparison of the lysis-centrifugation and radiometric systems for blood culture. J Clin Microbiol 1985; 22: 951–4.

    Google Scholar 

  32. Brannon P, Kiehn TE. Clinical comparison of lysis-centrifugation and radiometric resin systems for blood culture. J Clin Microbiol 1986; 24: 886–7.

    Google Scholar 

  33. Bille J, Stockman L, Roberts GD, Horstmeier CD, Ilstrup DM. Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood. J Clin Microbiol 1983; 18: 469–71.

    Google Scholar 

  34. Guerra-Romero L, Edson RS, Cockerill FR III, Horstmeier CD, Roberts GD. Comparison of Dupont Isolator and Roche Septi-Chek for detection of fungemia. J Clin Microbiol 1987; 25: 1623–5.

    Google Scholar 

  35. Murray PR. Comparison of the lysis-centrifugation and agitated biphasic blood culture systems for detection of fungemia. J Clin Microbiol 1991; 29: 96–8.

    Google Scholar 

  36. Murray PR, Spizo AW, Niles AC. Clinical comparison of the recoveries of bloodstream pathogens in Septi-Chek brain heart infusion broth with saponin, Septi-Chek tryptic soy broth, and the Isolator lysis-centrifugation system. J Clin Microbiol 1991; 29: 901–5.

    Google Scholar 

  37. Tarrand JJ, Guillot C, Wenglar M, Jackson J, Lajeunesse JD, Rolston KV. Clinical Comparison of the resin-containing B ACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol 1991; 29: 2245–9.

    Google Scholar 

  38. deRepentigny L. Serological techniques for diagnosis of fungal infection. Eur J Clin Microbiol Infect Dis 1989; 8: 362–75.

    Google Scholar 

  39. Platenkamp GJ, Van-Duin AM, Porsius JC, Schouten HJA, Zondervan PE, Michel MF. Diagnosis of invasive candidiasis in patients with and without signs of immune deficiency: a comparison of six detection methods in human serum. J Clin Pathol 1987; 40: 1162–7.

    Google Scholar 

  40. Araj GF, Hopfer RL, Chesnut S, Fainstein V, Body GP. Diagnostic value of the enzyme-linked immunosorbent assay for detection ofCandida albicans cytoplasmic antigen in sera of cancer patients. J Clin Microbiol 1982; 16: 46–52.

    Google Scholar 

  41. Cabezudo I, Pfaller M, Gerarden T, et al. Value of the Cand-TecCandida Antigen Assay in the diagnosis and therapy of systemic candidiasis in high-risk patients. Eur J Clin Microbiol Infect Dis 1989; 8: 770–7.

    Google Scholar 

  42. deRepentigny L, Marr LD, Keller JW, et al. Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients. J Clin Microbiol 1985; 21: 972–9.

    Google Scholar 

  43. Lew MA, Siber GR, Donahue DM, Maiorca F. Enhanced detection with an enzyme-linked immunosorbent assay ofCandida mannan in antibody-containing serum after heat extraction. J Infect Dis 1982; 145: 45–56.

    Google Scholar 

  44. Meckstroth KL, Reiss E, Keller JW, Kaufman L. Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay. J Infect Dis 1981; 144: 24–32.

    Google Scholar 

  45. Pfaller MA, Cabezudo I, Buschelman B, et al. Value of the HybritechCandida mannan assay in the diagnosis of disseminated candidiasis in high-risk patients. Abst 91st General Meeting of the Am Soc Microbiol. Abst. No. C-25, p 346.

  46. Sanchez ML, Pfaller MA, Cabezudo I, Bale M, Buschelman B. Diagnosis of disseminated candidiasis in hospitalized patients using the Cand-Tec latex agglutination assay. Mycopathologia 1992; 118: 152–62.

    Google Scholar 

  47. Segal E, Berg RA, Pizzo PA, Bennett JE. Detection ofCandida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Microbiol 1979; 10: 116–8.

    Google Scholar 

  48. deRepentigny L, Kuykendall RJ, Chandler FW, Broderson JR, Reiss E. Comparison of serum mannan, arabinitol, and mannose in experimental disseminated candidiasis. J Clin Microbiol 1984; 193: 804–11.

    Google Scholar 

  49. Wong B, Bernard EM, Gold JWM, Fong D, Silber A, Armstrong D. Increased arabinitol levels in experimental candidiasis in rats: Arabinitol appearance rate, arabinitol-/creatinine ratios, and severity of infection. J Infect Dis 1982; 146: 346–52.

    Google Scholar 

  50. Wong B, Baugman RP, Brauer KL. Levels of theCandida metabolite D-arabinitol in sera of steroid-treated and untreated patients with sarcoidosis. J Clin Microbiol 1989; 27: 1859–61.

    Google Scholar 

  51. Doebbeling BN, Hollis RJ, Isenberg HD, Wenzel RP, Pfaller MA. Restriction fragment analysis of aCandida tropicalis outbreak of sternal wound infections. J Clin Microbiol 1991; 29: 1268–70.

    Google Scholar 

  52. Howell SA, Noble WC. Typing tools for the investigation of epidemic fungal infection. Epidemiol Infect 1990; 105: 1–9.

    Google Scholar 

  53. Matthews R, Burnie J. Assessment of DNA fingerprinting for rapid identification of outbreaks of systemic candidiasis. Br Med J 1989; 298: 354–7.

    Google Scholar 

  54. Pfaller MA. Epidemiological typing for mycoses. Clin Infect Dis 1992; 14 (suppl): 54–10.

    Google Scholar 

  55. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990; 28: 2733–8.

    Google Scholar 

  56. Stevens DA, Odds FC, Scherer S. Applications of DNA typing methods toCandida albicans epidemiology and correlations with phenotype. Rev Infect Dis 1990; 12: 258–66.

    Google Scholar 

  57. Merz WG, Connelly C, Hieter P. Variation of electrophoretic karyotypes among clinical isolates ofCandida albicans. J Clin Microbiol 1988; 26: 842–5.

    Google Scholar 

  58. Pittet D, Monod M, Fithuth I, Frenk E, Suter PM, Auchenthaler R. Countour-clamped homogeneous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med 1992; 91 (suppl. 3B): 256S-263S.

    Google Scholar 

  59. Buchman TG, Tossier M, Merz WG. Detection of surgical pathogens by in vitro DNA amplification, Part I: Rapid indentification ofCandida albicans by in vitro amplification of a fungus-specific gene. Surgery 1990; 108: 38–47.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Oregon Health Sciences University, Portland, Oregon, USA

    Michael A. Pfaller MD

Authors
  1. Michael A. Pfaller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfaller, M.A. Laboratory aids in the diagnosis of invasive candidiasis. Mycopathologia 120, 65–72 (1992). https://doi.org/10.1007/BF00578290

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00578290

Key words

Search

Navigation